Abstract
Gene expression profiles of samples taken from patients with acute lung injury (ALI) induced by mechanical ventilation (MV) and lipopolysaccharide (LPS) were analyzed in order to identify key genes, and explore the underlying mechanisms. The GSE2411 microarray data set was downloaded from the Gene Expression Omnibus. This data set contained microarray data from 24 mouse lung samples, which were equally divided into four groups: Control group, MV group, LPS group and MV+LPS group. Differentially expressed genes (DEGs) were identified in the MV, LPS and MV+LPS groups, as compared with the control group, using packages of R software. Hierarchical clustering and between-group comparisons were performed for each group of DEGs. Overrepresented biological processes were revealed by functional enrichment analysis using the Database for Annotation, Visualization and Integrated Discovery. Unique DEGs in the LPS and MV+LPS groups were selected, and pathway enrichment analyses were performed using the Kyoto Encyclopedia of Genes and Genomes Orthology Based Annotation system. A total of 32, 264 and 685 DEGs were identified in the MV, LPS and MV+LPS groups, respectively. The MV+LPS group had more DEGs, as compared with the other two treatment groups. Genes associated with the immune and inflammatory responses were significantly overrepresented in both the LPS and MV+LPS groups, suggesting that LPS dominated the progression of ALI. Unique DEGs in the LPS and MV+LPS groups were associated with cytokine-cytokine receptor interaction. The Janus kinase-signal transducer and activator of transcription signaling pathway was shown to be enriched in the LPS+MV-unique DEGs. The results of the present study demonstrated that MV could exaggerate the transcriptional response of the lungs to LPS. Numerous key genes were identified, which may advance knowledge regarding the pathogenesis of ALI.
Keywords: acute lung injury, mechanical ventilation, lipopolysaccharide, hierarchical clustering, functional enrichment analysis, pathway enrichment analysis
Introduction
Acute lung injury (ALI) is a clinical syndrome associated with respiratory dysfunction, which is caused by numerous local or systemic inflammatory stimuli. ALI is predominantly caused by sepsis, and the rate of ALI-associated mortality is 50-60% (1).
Considerable experimental and clinical evidence has demonstrated that pro- and anti-inflammatory cytokines exhibit a major role in the pathogenesis of inflammatory-induced ALI (2-4). Numerous key genes and potential treatments for ALI have been proposed. Abraham et al (5) previously reported that high mobility group protein-1 is a distal mediator of inflammatory ALI. Furthermore, Imai et al (6) indicated that the Toll-like receptor 4 signaling pathway has a key role in ALI. Mei et al (7) demonstrated that mesenchymal stem cells overexpressing angiopoietin 1 were able to prevent lipopolysaccharide (LPS)-induced ALI in mice. In addition, caspase inhibitor (8), urinary trypsin inhibitor (9) and sphingosine 1-phosphate (10) have been shown to exhibit protective functions in LPS-induced ALI.
LPS is a major bioactive component of endotoxin, which can lead to sepsis and ALI (11). Rittirsch et al (12) previously reported that the migration inhibitory factor and leukotriene B4 mediator pathways are involved in the immunopathogenesis of LPS-induced experimental ALI; however, complement activation did not contribute to the development of ALI in an LPS model.
For patients with severely impaired respiratory function, mechanical ventilation (MV) is an essential means of treatment (13,14). MV provides effective respiratory support; however, it may also result in severe lung damage (15,16). Ranieri et al (17) previously verified that MV is able to induce a cytokine response, which may be attenuated by therapeutic strategies that minimize overdistention and recruitment/derecruitment of the lung. Therefore, determining the similarities and differences between MV- and LPS-induced ALI is required in order to produce more effective and safe treatment.
In the present study, gene expression profiles of mice with ALI induced by MV, LPS and MV+LPS were compared with controls, in order to identify differentially expressed genes (DEGs). Unique DEGs for each treatment group were screened, and the differences in the induction mechanisms between the groups were discussed.
Materials and methods
Gene expression data
The GSE2411 microarray data set (18) was downloaded from the Gene Expression Omnibus (19). Raw data were collected from 24 C57/B6 male mice, which were randomly divided into four groups: Control, phosphate-buffered saline (PBS) aspiration without MV; MV treatment, PBS with MV; LPS treatment, LPS aspiration without MV; and MV+LPS treatment. The annotation information for the chip was downloaded from the Mouse Expression 430A Array (GPL339 platform; Affymetrix, Santa Clara, CA, USA).
Data pre-treatment and differential analysis
The probes were mapped to genes according to the annotation files. When numerous probes were mapped to a single gene the values were averaged, in order to obtain the final expression levels. Log2 transformation and quantile normalization of the gene expression levels were conducted using the affy package (20) of R software (http://www.R-project.org). The three experimental groups were compared with the control group: Control vs. MV group; control vs. LPS group; and control vs. MV+LPS group. Statistical analyses were conducted using the multtest package (21) of R software, and numerous testing corrections were conducted using the Benjamin-Hochberg method (22). A false discovery rate (FDR)<0.05 and |logFC|>1 were set as the cut-off values, in order to screen for DEGs.
Cluster analysis
Hierarchical clustering (23) was performed for the DEGs identified from the three groups using cluster 3.0 program (version 1.47; http://rana.lbl.gov/EisenSoftware.html). The results were then visualized using Tree view program (http://rana.lbl.gov/EisenSoftware.html) (23).
Between-group comparisons of the DEGs
Student’s t-test (24) was used to examine the differences in the gene expression levels of the DEGs between the three experimental groups. P<0.05 was considered to indicate a statistically significant difference, and was used as a threshold value.
Functional enrichment analysis
To identify the altered biological functions following the various treatments, a functional enrichment analysis was conducted for the DEGs using the Database for Annotation, Visualization and Integrated Discovery (DAVID; http://www.david.niaid.nih.gov) (25). An FDR<0.05 was set as the cut-off value.
Screening of unique DEGs
The three experimental groups of DEGs were compared, in order to screen for unique DEGs in each experimental group (MV, LPS and MV+LPS groups). The unique DEGs were used to identify the molecular mechanism of ALI, induced by the corresponding treatment.
Pathway enrichment analysis of the unique DEGs
A pathway enrichment analysis of the unique DEGs was conducted using the Kyoto Encyclopedia of Genes and Genomes Orthology Based Annotation system (KOBAS; HTTP://KOBAS.CBI.PKU.EDU.CN) (26–27). An FDR<0.05 was set as the cut-off value.
Results
DEGs
The normalized gene expression data are presented in Fig. 1. A total of 32, 264 and 685 DEGs were identified in the MV, LPS and MV+LPS groups, as compared with the control group, respectively. Transcriptional response was detected in each group. Treatment with MV generated the smallest number of DEGs, followed by LPS treatment. Simultaneous application of the two treatments resulted in a significant increase in the transcriptional response.
Cluster analysis results
The cluster analysis results are shown in the upper section of Fig. 2. Each group of DEGs could be used to distinguish the corresponding experimental group from the control group. The MV group (Fig. 2A) had fewer DEGs, as compared with the LPS and MV+LPS groups (Fig. 2B and C).
Results of between-group comparisons
The expression levels of the DEGs in each experimental group were compared using a Student’s t-test (24). The results are presented in the lower section of Fig. 2. The MV+LPS group exhibited the highest degree of overexpression, as compared with the other groups. This result is concordant with the cluster analysis. A combination of MV and LPS stimulated the strongest transcriptional response in the lungs of the mice.
Functional enrichment analysis results
A Gene Ontology enrichment analysis was performed using DAVID, and the top 10 terms that met the threshold value (P<0.05) are presented in Table I. Negative regulation of catalytic activity was the most significantly enriched term in the MV group. Whereas, immune response was the most significantly enriched term in the LPS and MV+LPS groups, suggesting that LPS dominated the stimulation process of ALI. LPS increased the expression of genes associated with the immune and inflammatory response, whereas MV aggravated this effect.
Table I.
A, Control-MV
| ||
---|---|---|
Term | Count | FDR |
GO:0043086~negative regulation of catalytic activity | 5 | 3.23E-05 |
GO:0044092~negative regulation of molecular function | 5 | 9.19E-05 |
GO:0030595~leukocyte chemotaxis | 2 | 4.86E-02 |
GO:0060326~cell chemotaxis | 2 | 4.86E-02 |
| ||
B, Control-LPS | ||
| ||
Term | Count | FDR |
| ||
GO:0006955~immune response | 60 | 5.94E-34 |
GO:0006952~defense response | 51 | 1.07E-25 |
GO:0009611~response to wounding | 45 | 1.62E-24 |
GO:0006954~inflammatory response | 38 | 3.02E-24 |
GO:0007610~behavior | 28 | 3.39E-07 |
GO:0007626~locomotory behavior | 27 | 9.83E-12 |
GO:0042127~regulation of cell proliferation | 27 | 5.45E-04 |
GO:0006935~chemotaxis | 26 | 2.59E-19 |
GO:0042330~taxis | 26 | 2.59E-19 |
GO:0010033~response to organic substance | 23 | 2.44E-02 |
| ||
C, Control-MV+LPS | ||
| ||
Term | Count | FDR |
| ||
GO:0006955~immune response | 87 | 3.50E-32 |
GO:0009611~response to wounding | 68 | 7.48E-26 |
GO:0006954~inflammatory response | 54 | 2.80E-24 |
GO:0006952~defense response | 70 | 1.19E-20 |
GO:0042330~taxis | 32 | 7.08E-16 |
GO:0006935~chemotaxis | 32 | 7.08E-16 |
GO:0042127~regulation of cell proliferation | 62 | 2.63E-11 |
GO:0007626~locomotory behavior | 34 | 2.40E-07 |
GO:0001775~cell activation | 33 | 2.13E-06 |
GO:0001817~regulation of cytokine production | 24 | 4.65E-06 |
MV, mechanical ventilation; LPS, lipopolysaccharide; Count, number of enriched differentially expressed genes; FDR, false discovery rate.
Unique DEGs in each experimental group
The three groups of DEGs were compared, in order to identify unique DEGs in each experimental group. A total of 421 unique DEGs were identified in the MV+LPS group, as compared with MV and LPS groups, whereas 246 unique DEGs were identified in the LPS group, as compared with the MV group (Fig. 3).
Pathway enrichment analysis results
A pathway enrichment analysis was performed for the two groups of unique DEGs (LPS-unique and MV+LPS-unique), using KOBAS. The overrepresented pathways are presented in Table II. Cytokine-cytokine receptor interaction was the most significantly enriched term in both groups of unique DEGs. The Janus kinase-signal transducer and activator of transcription (Jak-STAT) signaling pathway was enriched for in the LPS+MV-unique DEGs.
Table II.
A, LPS-unique
| |||
---|---|---|---|
Pathway ID | Pathway name | Count | FDR |
mmu04060 | Cytokine-cytokine receptor interaction | 30 | 2.44E-13 |
mmu04062 | Chemokine signaling pathway | 19 | 4.93E-06 |
mmu04621 | NOD-like receptor signaling pathway | 12 | 1.42E-05 |
mmu04620 | Toll-like receptor signaling pathway | 13 | 2.48E-04 |
| |||
B, LPS+MV-unique | |||
| |||
Pathway ID | Pathway name | Count | FDR |
| |||
mmu04060 | Cytokine-cytokine receptor interaction | 22 | 1.62E-05 |
mmu04062 | Chemokine signaling pathway | 14 | 3.88E-03 |
mmu04630 | Jak-STAT signaling pathway | 12 | 7.01E-03 |
mmu04620 | Toll-like receptor signaling pathway | 9 | 1.10E-02 |
mmu00760 | Nicotinate and nicotinamide metabolism | 4 | 4.03E-02 |
mmu00071 | Fatty acid metabolism | 5 | 4.89E-02 |
mmu01040 | Biosynthesis of unsaturated fatty acids | 4 | 4.91E-02 |
LPS, lipopolysaccharide; MV, mechanical ventilation; Count, number of enriched differentially expressed gene; FDR, false discovery rate.
Discussion
The present study identified 32, 264 and 685 DEGs in the MV, LPS, and MV+LPS groups, respectively. The transcriptional response of the lungs was observed in the MV and LPS treatment groups; however, the MV+LPS generated the most DEGs, thus suggesting that MV is able to augment the influence of LPS on gene expression. MV exerted a smaller disturbance on the transcription of genes in the lungs, as compared with LPS, which was further verified by a cluster analysis and between-group comparisons. The underlying mechanism of the effects of MV was obviously different from that of LPS. Negative regulation of catalytic activity was the most significant biological process enriched for in the DEGs of MV, whereas the immune and inflammatory response were the most significantly enriched terms in the DEGs of the LPS and MV+LPS groups.
In order to further determine the differences between the two treatments in causing ALI, the identified DEGs from each experimental group were compared. A total of 246 out of the 264 identified DEGs were unique to the LPS group, as compared with the MV group. A total of 421 novel DEGs were identified in the MV+LPS group, as compared with the MV and LPS groups. Cytokine-cytokine receptor interaction was the most significantly enriched pathway in the LPS-unique and MV+LPS-unique DEGs, which verified the role of the inflammatory response in the pathogenesis of ALI. This result also suggested that MV could exaggerate the degree of inflammation in the lungs, as more cytokines were dysregulated.
Cytokines are synthesized and secreted by inflammatory cells, and have a wide range of biological activities. Cytokines are involved in the regulation of immune cell differentiation and development, and the immune and inflammatory response (28). They are considered to have important roles in ALI (29). In the present study, members of the CXC subfamily, CC subfamily, tumor necrosis factor (TNF)-receptor superfamily and interleukin (IL)-1 cytokine family were shown to be differentially expressed. Chemokine (C-X-C motif) ligand 1 (CXCL1) has previously been shown to have a role in inflammation, and functions as a chemoattractant for neutrophils (30,31). In addition, IL-6 is secreted into the serum, and induces a transcriptional inflammatory response through IL-6 receptor α (32,33). Ahuja et al (34) previously reported that circulating IL-6 mediates lung injury, via CXCL1 production following acute kidney injury in mice. IL-1β is a family of proinflammatory cytokines, which are hypothesized to be involved in numerous acute and chronic diseases (35). Kolb et al (36) previously demonstrated that transient expression of IL-1β was able to induce ALI. Furthermore, CCL2 is involved in inflammatory disorders of the lung, and it has been suggested that it may contribute to ALI (37). Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with ALI (38). Furthermore, numerous members of the colony stimulating factors (CSFs) were identified in ALI in the present study, such as CSF1, CSF2 and CSF3. CSFs have been shown to exhibit protective effects on ALI (39-41). These results suggest that the findings of the present study may be useful in guiding the further investigation of ALI.
The Jak-STAT signaling pathway was shown to be enriched in the MV+LPS-unique DEGs. The Jak-STAT pathway participates in transcriptional activation in response to interferons, and other extracellular signaling proteins (42). It is important in regulating cytokine-dependent gene expression, and cellular development and survival (43). Previous studies have demonstrated that the STAT pathway is activated in ALI (44-45). Severgnini et al (46) previously showed that inhibition of Src and Jak kinases resulted in protection against LPS-induced ALI. Therefore, the present study hypothesized that DEGs associated with this pathway may be potential therapeutic targets. CSF3 is a cytokine that controls the production, differentiation, and function of granulocytes (47). Hierholzer et al (48) reported that the presence of G-CSF alone in the lung can lead to the recruitment of neutrophils, lung injury, and impaired pulmonary function, thus suggesting that the local production of G-CSF may contribute to the development of lung damage and possibly ALI. Furthermore, Suratt et al (49) showed that plasma levels of G-CSF correlate with clinical outcomes in patients with ALI. Pim kinases are a family of serine/threonine kinases whose activity can be induced by allergy-associated cytokines (50). Shin et al (50) previously reported that inhibition of Pim1 kinase activation attenuated allergen-induced airway hyperresponsiveness and inflammation. Therefore, Pim1 may exert similar functions in ALI and could be a potential therapeutic target.
Fatty acid metabolism was also found to be significantly enriched for in the MV+LPS-unique DEGs. Murray et al (51) demonstrated that select dietary fatty acids are able to attenuate cardiopulmonary dysfunction, during ALI in pigs. However, Rice et al (52) reported that twice-daily enteral supplementation of omega-3 fatty acids, γ-linolenic acid and antioxidants did not improve the primary end-point of ventilator-free days, or other clinical outcomes in patients with ALI, and may be harmful. Therefore, although certain findings have been obtained, the association between fatty acid metabolism and ALI remains under debate.
In conclusion, the present study discussed the similarities and differences between MV- and LPS-induced ALI. These findings not only supplement the current knowledge regarding ALI, but may also provide potential biomarkers for the diagnosis and treatment of ALI.
Acknowledgments
The present study was supported by the National Natural Science Fund (grant no. 81170028).
References
- 1.Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149:818–824. doi: 10.1164/ajrccm.149.3.7509706. [DOI] [PubMed] [Google Scholar]
- 2.Goodman RB, Pugin J, Lee JS, Matthay MA. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev. 2003;14:523–535. doi: 10.1016/S1359-6101(03)00059-5. [DOI] [PubMed] [Google Scholar]
- 3.Dolinay T, Kim YS, Howrylak J, et al. Inflammasome-regulated cytokines are critical mediators of acute lung injury. Am J Respir Crit Care Med. 2012;185:1225–1234. doi: 10.1164/rccm.201201-0003OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Bhatia M, Zemans RL, Jeyaseelan S. Role of chemokines in the pathogenesis of acute lung injury. Am J Respir Cell Mol Biol. 2012;46:566–572. doi: 10.1165/rcmb.2011-0392TR. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ. HMG-1 as a mediator of acute lung inflammation. J Immunol. 2000;165:2950–2954. doi: 10.4049/jimmunol.165.6.2950. [DOI] [PubMed] [Google Scholar]
- 6.Imai Y, Kuba K, Neely GG, et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 2008;133:235–249. doi: 10.1016/j.cell.2008.02.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Mei SH, McCarter SD, Deng Y, et al. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med. 2007;4:e269. doi: 10.1371/journal.pmed.0040269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Kawasaki M, Kuwano K, Hagimoto N, et al. Protection from lethal apoptosis in lipopolysaccharide-induced acute lung injury in mice by a caspase inhibitor. Am J Pathol. 2000;157:597–603. doi: 10.1016/S0002-9440(10)64570-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Inoue K, Takano H, Yanagisawa R, et al. Protective role of urinary trypsin inhibitor in acute lung injury induced by lipopolysaccharide. Exp Biol Med (Maywood) 2005;230:281–287. doi: 10.1177/153537020523000408. [DOI] [PubMed] [Google Scholar]
- 10.Peng X, Hassoun PM, Sammani S, et al. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med. 2004;169:1245–1251. doi: 10.1164/rccm.200309-1258OC. [DOI] [PubMed] [Google Scholar]
- 11.Li T, Zhang J, Feng J, et al. Resveratrol reduces acute lung injury in a LPS-induced sepsis mouse model via activation of Sirt1. Mol Med Rep. 2013;7:1889–1895. doi: 10.3892/mmr.2013.1444. [DOI] [PubMed] [Google Scholar]
- 12.Rittirsch D, Flierl MA, Day DE, et al. Acute lung injury induced by lipopolysaccharide is independent of complement activation. J Immunol. 2008;180:7664–7672. doi: 10.4049/jimmunol.180.11.7664. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.López-Cuenca S, Morales-García S, Martín-Hita A, Frutos-Vivar F, Fernández-Segoviano P, Esteban A. Severe acute respiratory failure secondary to acute fibrinous and organizing pneumonia requiring mechanical ventilation: a case report and literature review. Respir Care. 2012;57:1337–1341. doi: 10.4187/respcare.01452. [DOI] [PubMed] [Google Scholar]
- 14.Bouferrache K, Vieillard-Baron A. Acute respiratory distress syndrome, mechanical ventilation, and right ventricular function. Curr Opin Crit Care. 2011;17:30–35. doi: 10.1097/MCC.0b013e328342722b. [DOI] [PubMed] [Google Scholar]
- 15.Slutsky AS. Lung injury caused by mechanical ventilation. Chest J. 1999;116:9S–15S. doi: 10.1378/chest.116.suppl_1.9S-a. [DOI] [PubMed] [Google Scholar]
- 16.Gajic O, Dara SI, Mendez JL, et al. Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation. Crit Care Med. 2004;32:1817–1824. doi: 10.1097/01.CCM.0000133019.52531.30. [DOI] [PubMed] [Google Scholar]
- 17.Ranieri VM, Suter PM, Tortorella C, et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1999;282:54–61. doi: 10.1001/jama.282.1.54. [DOI] [PubMed] [Google Scholar]
- 18.Altemeier WA, Matute-Bello G, Gharib SA, Glenny RW, Martin TR, Liles WC. Modulation of lipopolysaccharide-induced gene transcription and promotion of lung injury by mechanical ventilation. J Immunol. 2005;175:3369–3376. doi: 10.4049/jimmunol.175.5.3369. [DOI] [PubMed] [Google Scholar]
- 19.Barrett T, Suzek TO, Troup DB, et al. NCBI GEO: mining millions of expression profiles - database and tools. Nucleic Acids Res. 2005;33:D562–D566. doi: 10.1093/nar/gki022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Fujita A, Sato JR, Rodrigues Lde O, Ferreira CE, Sogayar MC. Evaluating different methods of microarray data normalization. BMC Bioinformatics. 2006;7:469. doi: 10.1186/1471-2105-7-469. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Smyth GK. Limma: linear models for microarray data. In: Gentleman R, Carey VM Dudoit S, Irizarry R, Huber W, editors. Bioinformatics and computational biology solutions using R and Bioconductor. Springer; New York: 2005. pp. 397–420. [DOI] [Google Scholar]
- 22.Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Statist Soc Ser B (Methodological) 1995;57:289–300. [Google Scholar]
- 23.Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 1998;95:14863–14868. doi: 10.1073/pnas.95.25.14863. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Hsu CL, Lee WC. Detecting differentially expressed genes in heterogeneous diseases using half Student’s t-test. Int J Epidemiol. 2010;39:1597–1604. doi: 10.1093/ije/dyq093. [DOI] [PubMed] [Google Scholar]
- 25.Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57. doi: 10.1038/nprot.2008.211. [DOI] [PubMed] [Google Scholar]
- 26.Wu J, Mao X, Cai T, Luo J, Wei L. KOBAS server: a web-based platform for automated annotation and pathway identification. Nucleic Acids Res. 2006;34:W720–W724. doi: 10.1093/nar/gkl167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Xie C, Mao X, Huang J, et al. KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases. Nucleic Acids Res. 2011;39:W316–W322. doi: 10.1093/nar/gkr483. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med. 1998;338:436–445. doi: 10.1056/NEJM199802123380706. [DOI] [PubMed] [Google Scholar]
- 29.Murphy TJ, Paterson HM, Kriynovich S, et al. Linking the "two-hit" response following injury to enhanced TLR4 reactivity. J Leukoc Biol. 2005;77:16–23. doi: 10.1189/jlb.0704382. [DOI] [PubMed] [Google Scholar]
- 30.Jin L, Batra S, Douda DN, Palaniyar N, Jeyaseelan S. CXCL1 Contributes to Host Defense in Polymicrobial Sepsis via Modulating T Cell and Neutrophil Functions. J Immunol. 2014;193:3549–3558. doi: 10.4049/jimmunol.1401138. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.De Filippo K, Dudeck A, Hasenberg M, et al. Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood. 2013;121:4930–4937. doi: 10.1182/blood-2013-02-486217. [DOI] [PubMed] [Google Scholar]
- 32.Mihara M, Hashizume M, Yoshida H, Suzuki M, Shiina M. IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clin Sci (Lond) 2012;122:143–159. doi: 10.1042/CS20110340. [DOI] [PubMed] [Google Scholar]
- 33.Rose-John S. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Int J Biol Sci. 2012;8:1237–1247. doi: 10.7150/ijbs.4989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Ahuja N, Andres-Hernando A, Altmann C, et al. Circulating IL-6 mediates lung injury via CXCL1 production after acute kidney injury in mice. Am J Physiol Renal Physiol. 2012;303:F864–F872. doi: 10.1152/ajprenal.00025.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Dinarello CA. Blocking interleukin-1β in acute and chronic autoinflammatory diseases. J Intern Med. 2011;269:16–28. doi: 10.1111/j.1365-2796.2010.02313.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Kolb M, Margetts PJ, Anthony DC, Pitossi F, Gauldie J. Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest. 2001;107:1529–1536. doi: 10.1172/JCI12568. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Rose CE, Jr, Sung SS, Fu SM. Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung. Microcirculation. 2003;10:273–288. doi: 10.1080/mic.10.3-4.273.288. [DOI] [PubMed] [Google Scholar]
- 38.Parsons PE, Matthay MA, Ware LB, Eisner MD, National Heart, Lung, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Network Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2005;288:L426–L431. doi: 10.1152/ajplung.00302.2004. [DOI] [PubMed] [Google Scholar]
- 39.Jeon GW, Sung DK, Jung YJ, et al. Granulocyte colony stimulating factor attenuates hyperoxia-induced lung injury by down-modulating inflammatory responses in neonatal rats. Yonsei Med J. 2011;52:65–73. doi: 10.3349/ymj.2011.52.1.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Standiford LR, Standiford TJ, Newstead MJ, et al. TLR4-dependent GM-CSF protects against lung injury in Gram-negative bacterial pneumonia. Am J Physiol Lung Cell Mol Physiol. 2012;302:L447–L454. doi: 10.1152/ajplung.00415.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Yamaguchi T, Miyata Y, Hayamizu K, et al. Preventive effect of G-CSF on acute lung injury via alveolar macrophage regulation. J Surg Res. 2012;178:378–384. doi: 10.1016/j.jss.2011.12.026. [DOI] [PubMed] [Google Scholar]
- 42.Darnell JE, Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994;264:1415–1421. doi: 10.1126/science.8197455. [DOI] [PubMed] [Google Scholar]
- 43.O’Shea JJ, Gadina M, Schreiber RD. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell. 2002;109:S121–S131. doi: 10.1016/S0092-8674(02)00701-8. [DOI] [PubMed] [Google Scholar]
- 44.Severgnini M, Takahashi S, Rozo LM, et al. Activation of the STAT pathway in acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2004;286:L1282–L1292. doi: 10.1152/ajplung.00349.2003. [DOI] [PubMed] [Google Scholar]
- 45.Gao H, Guo RF, Speyer CL, et al. Stat3 activation in acute lung injury. J Immunol. 2004;172:7703–7712. doi: 10.4049/jimmunol.172.12.7703. [DOI] [PubMed] [Google Scholar]
- 46.Severgnini M, Takahashi S, Tu P, et al. Inhibition of the Src and Jak kinases protects against lipopolysaccharide-induced acute lung injury. Am J Respir Crit Care Med. 2005;171:858–867. doi: 10.1164/rccm.200407-981OC. [DOI] [PubMed] [Google Scholar]
- 47.Tchatalbachev S, Ghai R, Hossain H, Chakraborty T. Gram-positive pathogenic bacteria induce a common early response in human monocytes. BMC Microbiol. 2010;10:275. doi: 10.1186/1471-2180-10-275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Hierholzer C, Kelly E, Lyons V, et al. G-CSF instillation into rat lungs mediates neutrophil recruitment, pulmonary edema and hypoxia. J Leukoc Biol. 1998;63:169–174. doi: 10.1002/jlb.63.2.169. [DOI] [PubMed] [Google Scholar]
- 49.Suratt BT, Eisner MD, Calfee CS, et al. NHLBI Acute Respiratory Distress Syndrome Network: Plasma granulocyte colony-stimulating factor levels correlate with clinical outcomes in patients with acute lung injury. Crit Care Med. 2009;37:1322–1328. doi: 10.1097/CCM.0b013e31819c14fa. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Shin YS, Takeda K, Shiraishi Y, et al. Inhibition of Pim1 kinase activation attenuates allergen-induced airway hyperresponsiveness and inflammation. Am J Respir Cell Mol Biol. 2012;46:488–497. doi: 10.1165/rcmb.2011-0190OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Murray MJ, Kumar M, Gregory TJ, et al. Select dietary fatty acids attenuate cardiopulmonary dysfunction during acute lung injury in pigs. Am J Physiol. 1995;269:H2090–H2099. doi: 10.1152/ajpheart.1995.269.6.H2090. [DOI] [PubMed] [Google Scholar]
- 52.Rice TW, Wheeler AP, Thompson BT, et al. NIH NHLBI Acute Respiratory Syndrome Network of Investigators: Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury. JAMA. 2011;306:1574–1581. doi: 10.1001/jama.2011.1435. [DOI] [PMC free article] [PubMed] [Google Scholar]